Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig Hendrix

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
The Lancet. HIV|September 24, 2016
When is a PrEP candidate ready for phase 3?Craig Hendrix
Antiviral Research|November 27, 2010
Clinical evaluation of microbicide formulationsKathleen M Morrow, Craig Hendrix
Journal of the International AIDS Society|May 19, 2025
Dosing forgiveness of oral PrEP for cisgender women remains uncertainMia Moore, David Glidden, Peter Anderson, et al.
The Annals of Applied Statistics|June 29, 2011
NONLINEAR TUBE-FITTING FOR THE ANALYSIS OF ANATOMICAL AND FUNCTIONAL STRUCTURESJeff Goldsmith, Brian Caffo, Ciprian Crainiceanu, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 5, 2015
Enema ion compositions for enhancing colorectal drug deliveryKatharina Maisel, Sumon Chattopadhyay, Thomas Moench, et al.
CPT: Pharmacometrics & Systems Pharmacology|February 6, 2021
A Mechanistic In Vivo/Ex Vivo Pharmacokinetic-Pharmacodynamic Model of Tenofovir for HIV PreventionPriya Jayachandran, Maria Garcia-Cremades, Katarina Vučićević, et al.
AIDS (London, England)|February 25, 2003
A phase I/II study of nevirapine for pre-exposure prophylaxis of HIV-1 transmission in uninfected subjects at high riskJ Brooks Jackson, Scott Barnett, Estelle Piwowar-Manning, et al.
AIDS Research and Human Retroviruses|May 16, 2024
The Global Impact of Diversifying PrEP Options: Results of an International Discrete Choice Experiment of Existing and Potential PrEP Strategies with Gay and Bisexual Men and PhysiciansChristine Tagliaferri Rael, Rebecca Giguere, Ewa Bryndza Tfaily, et al.
BMC Complementary and Alternative Medicine|August 21, 2008
Pharmacokinetic and metabolic effects of American ginseng (Panax quinquefolius) in healthy volunteers receiving the HIV protease inhibitor indinavirAdriana S A Andrade, Craig Hendrix, Teresa L Parsons, et al.
AIDS and Behavior|November 2, 2017
Utility of Different Adherence Measures for PrEP: Patterns and Incremental ValueAndrew Abaasa, Craig Hendrix, Monica Gandhi, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
The Lancet. HIV|September 24, 2016
When is a PrEP candidate ready for phase 3?Craig Hendrix
Antiviral Research|November 27, 2010
Clinical evaluation of microbicide formulationsKathleen M Morrow, Craig Hendrix
Journal of the International AIDS Society|May 19, 2025
Dosing forgiveness of oral PrEP for cisgender women remains uncertainMia Moore, David Glidden, Peter Anderson, et al.
The Annals of Applied Statistics|June 29, 2011
NONLINEAR TUBE-FITTING FOR THE ANALYSIS OF ANATOMICAL AND FUNCTIONAL STRUCTURESJeff Goldsmith, Brian Caffo, Ciprian Crainiceanu, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 5, 2015
Enema ion compositions for enhancing colorectal drug deliveryKatharina Maisel, Sumon Chattopadhyay, Thomas Moench, et al.
CPT: Pharmacometrics & Systems Pharmacology|February 6, 2021
A Mechanistic In Vivo/Ex Vivo Pharmacokinetic-Pharmacodynamic Model of Tenofovir for HIV PreventionPriya Jayachandran, Maria Garcia-Cremades, Katarina Vučićević, et al.
AIDS (London, England)|February 25, 2003
A phase I/II study of nevirapine for pre-exposure prophylaxis of HIV-1 transmission in uninfected subjects at high riskJ Brooks Jackson, Scott Barnett, Estelle Piwowar-Manning, et al.
AIDS Research and Human Retroviruses|May 16, 2024
The Global Impact of Diversifying PrEP Options: Results of an International Discrete Choice Experiment of Existing and Potential PrEP Strategies with Gay and Bisexual Men and PhysiciansChristine Tagliaferri Rael, Rebecca Giguere, Ewa Bryndza Tfaily, et al.
BMC Complementary and Alternative Medicine|August 21, 2008
Pharmacokinetic and metabolic effects of American ginseng (Panax quinquefolius) in healthy volunteers receiving the HIV protease inhibitor indinavirAdriana S A Andrade, Craig Hendrix, Teresa L Parsons, et al.
AIDS and Behavior|November 2, 2017
Utility of Different Adherence Measures for PrEP: Patterns and Incremental ValueAndrew Abaasa, Craig Hendrix, Monica Gandhi, et al.
Pageof 4